Therefore, HMGB1 might serve as a regulatory target for drug resistance and a prognostic marker for malignant tumors, it has a promising clinical application as a target for tumor therapy and various HMGB1-targeted drugs have been developed recently [2]. The gene discussed is HMGB1; the disease is cancer.